Comment from Anonymous
AnonymousOpposeIndividual
Summary: The commenter opposes the proposed action, arguing that GLP-1 compounds are necessary for treating chronic illnesses like Lipedema and obesity, especially for those without insurance coverage. They suggest that if compounding pharmacies are restricted, insurance companies must instead provide coverage for these conditions.
I disagree. For a person who uses the compounds of GLP-1, it’s not always used for cosmetic issues. It’s an access issue.
It’s the way that Americans with chronic illnesses that are not covered by insurance such as Lipedema can seek comfort and still afford to live comfortably.
If this passes and compounding pharmacies are not allowed to fill this gap, insurance companies need to start covering for obesity and other chronic illnesses, such as Lipedema or other inflammatory illnesses.